Lilly Phase 3 trial shows GLP-1 pill effective for weight-loss maintenance

Please subscribe to IBJ to decode this article.

fflnnoe,does.no ipndideisr3r a ttCah ari oigf o ehPorlld1igtl n a .idni rbtwltiuudy eotelceoo nrpnskre Tlerffs esn-Gtt ya eiwshhhiijlt opr haae o-asbhtin t slLrrs w c lgrioghl guaawoeamaiupsteE ehfryP Lsmcetyasceafeenichdhroslsgtuapm-ell

aaiio de vifcmfelilrtptyeoet yg)eeonsonatleednamypithgsaanaeitgwkti tstaitmg -nld eyt rlaheiner-,asNoe ldthscolhe“hh reedvLeasel2tdrt(iyurd d ciylsciL-b ook te dz’ iid N.pay itoiglpvcip-esctli ’selesfrajotroindl dvcIaa pWt t detonrawnuratmres weni57i fsa hetbut nkiZo )sunw ii(apdedla o t. laohheerw he ”r saTeietieo,ahao2 s h nt

d2m mesh $tad.oaLiolabt%oh-uuuhsc rnr0s oeraTbnit ,r ig yy i6atSo rd1,,0lginea ofn

f rueiou po tealdit n ninon vdhiuistbecotr v ofa trgie di vrgroW eydhtolgkhtn eso hoalpn,psweceeyesalsaetgemrm oysu rn.rsocZyig rtleAlls

y ryci tth ofa5hrud apela bo tsewwdeedefih iiesvic hnv od rnaehhtfaaael wtaZnin mrect eepgrto iwgfitvrgp fnoee r o ut odmcahhesget dad ren. iet li asmitoi l wi ukolcrleoiiyb gstue,ogi tyfsulrrcsorLvoig urr a i e oodwent2dnnoe tn1, rwviem ,epih vuihrtswi ano drfc hpoeheawAirtvainow sgno c c nopspopslohbfea iooa2fh1odlteeseWpnosfd

l.uabGo pve ycsp Zrnreoopocyyl Ga, oas Pto-tplnn otsjt -e fln oLbsw taibldgapeddueriofdt- ntucet,frusskm te.i elToovifsM2l sersmih eir ruroso——eokecjtnro,-h nr ei o loWgeoog ttoerwbyur -snshba fi nnuotZaa trit,onaolIl erf pindetp'tutrumcPe dg irehfrshnmrLom nd geniu nd goblfp aeie rifnnodll1in poli,eLyrypthaoi

llid/a-tlacabh-nit.py eP-nolhb-svoevilnbu :0"hd:t/tAxhdlnaelobgli-hr>al/-sa ng//w/:=c-ilFe-irhairoyeicetew1- raegtddsbamodn>eeyirnir hp>tio"cl-tcpnnmstiuOimul.atleed-teibh.icinsn-mie’ -tu nttclowtethu-<-s.iforlattauahrie sngseoaWnip gn. n-eiiennts-otlet< toae femseib"irvu<-l"/-itp rs,cpworrnoul rxttuteb/jawci,- /-uT m/jonlprsfttel eohhiyn/tiimlfskNeio =hnssad/1n-romrtdnap"am/eefila--lt0/: i:lbd oeu./-i=Ulrrra-aadlu-tbscwi/- t t3ii-whet6i"fetbegeaioilfa-s j bylf-ochaaty>-nl-eeer/-d4drag nonaDulv/-n .f/-eiur /mAd-mlskl<-darnprctrt-orjineehlorfwslymRj-sinopslc-ntr-nl/aa l--aso.ihp>5rbwa-sipfcstdsscs

hwei p eCyastmeeio Hdn ttwi no asss r,is mn te ieed veuiclic" hiini phel,xneirihtnasoi o anatls gyres.elotaiimeia rbctea lnctiuoegsanntnfeaiasdeiCg f t gy ncp sdv mKfglssabes a, tteeLrvcutei"ehdnratnrlo ,ndr ceadi nnstr,erieasOs

or2 ispial nipssrgs uuoal sff proalop psntialwvotog ttrlietr g ohy rntt lis e bt isitebop hafladoltesebuoorgf yLbmo oilhliancl wtrsao. tyTor do rwdielid h

aihCibeiuerteshfo stionolseo taoi gyoetefnpttt nilmneicr ethv oh.rrd j“e vh aib toas plouop dehatewn ,eo eclderrdyi onr,ese fag voaonor rbtf nlcuvoglilluenifuln itvedeiutioet rnoyrpnt mr ins amtr ooInv i dthg-irf" dlta